Remed Statistics

Total Valuation

Remed has a market cap or net worth of KRW 98.44 billion. The enterprise value is 89.61 billion.

Market Cap	98.44B
Enterprise Value	89.61B

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Remed has 30.91 million shares outstanding. The number of shares has increased by 9.70% in one year.

Current Share Class	30.91M
Shares Outstanding	30.91M
Shares Change (YoY)	+9.70%
Shares Change (QoQ)	+0.79%
Owned by Insiders (%)	35.92%
Owned by Institutions (%)	2.08%
Float	19.80M

Valuation Ratios

The trailing PE ratio is 30.76.

PE Ratio	30.76
Forward PE	n/a
PS Ratio	4.06
PB Ratio	2.32
P/TBV Ratio	2.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 50.39, with an EV/FCF ratio of -24.92.

EV / Earnings	27.34
EV / Sales	3.69
EV / EBITDA	50.39
EV / EBIT	211.10
EV / FCF	-24.92

Financial Position

The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.07.

Current Ratio	3.86
Quick Ratio	2.57
Debt / Equity	0.07
Debt / EBITDA	1.67
Debt / FCF	-0.82
Interest Coverage	0.44

Financial Efficiency

Return on equity (ROE) is 7.99% and return on invested capital (ROIC) is 0.53%.

Return on Equity (ROE)	7.99%
Return on Assets (ROA)	0.44%
Return on Invested Capital (ROIC)	0.53%
Return on Capital Employed (ROCE)	0.89%
Revenue Per Employee	263.65M
Profits Per Employee	35.63M
Employee Count	89
Asset Turnover	0.40
Inventory Turnover	1.33

Taxes

In the past 12 months, Remed has paid 77.52 million in taxes.

Income Tax	77.52M
Effective Tax Rate	2.31%

Stock Price Statistics

The stock price has decreased by -16.29% in the last 52 weeks. The beta is 0.79, so Remed's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-16.29%
50-Day Moving Average	3,326.60
200-Day Moving Average	3,373.73
Relative Strength Index (RSI)	48.50
Average Volume (20 Days)	73,696

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Remed had revenue of KRW 24.26 billion and earned 3.28 billion in profits. Earnings per share was 103.55.

Revenue	24.26B
Gross Profit	14.28B
Operating Income	424.48M
Pretax Income	3.36B
Net Income	3.28B
EBITDA	1.78B
EBIT	424.48M
Earnings Per Share (EPS)	103.55

Full Income Statement

Balance Sheet

The company has 13.69 billion in cash and 2.96 billion in debt, giving a net cash position of 10.73 billion or 347.05 per share.

Cash & Cash Equivalents	13.69B
Total Debt	2.96B
Net Cash	10.73B
Net Cash Per Share	347.05
Equity (Book Value)	42.44B
Book Value Per Share	1,311.81
Working Capital	22.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.88 billion and capital expenditures -719.84 million, giving a free cash flow of -3.60 billion.

Operating Cash Flow	-2.88B
Capital Expenditures	-719.84M
Free Cash Flow	-3.60B
FCF Per Share	-116.36

Full Cash Flow Statement

Margins

Gross margin is 58.85%, with operating and profit margins of 1.75% and 13.51%.

Gross Margin	58.85%
Operating Margin	1.75%
Pretax Margin	13.85%
Profit Margin	13.51%
EBITDA Margin	7.33%
EBIT Margin	1.75%
FCF Margin	n/a

Dividends & Yields

Remed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.70%
Shareholder Yield	-9.70%
Earnings Yield	3.33%
FCF Yield	-3.65%

Stock Splits

The last stock split was on December 8, 2023. It was a forward split with a ratio of 5.

Last Split Date	Dec 8, 2023
Split Type	Forward
Split Ratio	5

Scores

Remed has an Altman Z-Score of 6.19 and a Piotroski F-Score of 6.

Altman Z-Score	6.19
Piotroski F-Score	6